This test is non-MBS rebateable and should be accompanied by a patient consent form.
HMG-CoA Reductase (3-hydroxy-3-methylglutaryl-coenzyme A Reductase) antibodies are associated with autoimmune (immune-mediated) necrotizing myopathies.
More than 60% of patients with anti-HMG-CoA reductase antibodies have current or previous exposure to statin therapy.
Autoantibody levels to HMG-CoA reductase correlate to clinical findings and CK levels.
The manifestations of anti-HMG-CoA reductase statin-associated immune-mediated necrotizing myopathy mainly affect skeletal muscle.
|